{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":42,"n_cols":5,"rows_kept":42,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[11,2,11,3],[12,2,12,3],[16,2,16,3],[22,2,22,3],[22,4,22,5],[23,2,23,3],[23,4,23,5],[24,2,24,3],[25,2,25,3],[26,2,26,3],[27,2,27,3],[39,2,39,3],[40,2,40,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910791535403321"]
[null,null,"Autore",null,"Wheless James"]
[null,null,"Titolo",null,"Advanced therapy in epilepsy [[electronic resource] /] / James Wheless, L. James Willmore, Roger A. Brumback"]
[null,null,"Pubbl/distr/stampa",null,"Shelton, CT, : People's Medical Publishing House"]
[{"$nulls":4},"London, : McGraw-Hill [distributor], c2009"]
[null,null,"ISBN",null,"1-60795-124-X"]
[null,null,"Descrizione fisica",null,"1 online resource (489 p.)"]
[null,null,"Disciplina",null,"616.853"]
[null,null,"Soggetti",null,"Epilepsy"]
[{"$nulls":4},"Epilepsy - Treatment"]
[{"$nulls":4},"Epilepsy - Diagnosis"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"\"\"Title and Front matter\"\"; \"\"Preface\"\"; \"\"Contents\"\"; \"\"1. Introduction\"\"; \"\"2. Epilepsy: Brief Historical Perspective\"\"; \"\"3. Definitions and Classification of Epilepsy and Seizures\"\"; \"\"4. Neurophysiologic Basis of Epileptiform Activity\"\"; \"\"5. Epidemiology\"\"; \"\"6. Magnetoencephalography in the Diagnosis and Treatment of Epilepsy\"\"; \"\"7. Clinical Neurophysiology: Other Techniques\"\"; \"\"8. Neuroimaging in Epilepsy\"\"; \"\"9. Experimental Models of Seizures and Epilepsy\"\"; \"\"10. The EEG of Epilepsy\"\"; \"\"11. Genetic and Chromosomal Disorders in Epilepsy\"\""]
[{"$nulls":4},"\"\"12. Neuropathology of Pediatric Cerebral Resections for Epilepsy\"\"\"\"13. Neurometabolic Disorders and Epilepsy\"\"; \"\"14. Neurocutaneous Disorders and Epilepsy\"\"; \"\"15. Neonatal Seizures\"\"; \"\"16. Epilepsy in Developmental Disorders\"\"; \"\"17. Epilepsy in Neurodegenerative Diseases\"\"; \"\"18. Acquired Lesions and Epilepsy\"\"; \"\"19. Febrile Seizures\"\"; \"\"20. Convulsive Status Epilepticus\"\"; \"\"21. Clinical Features, Diagnosis, and Treatment of Nonconvulsive Status Epilepticus\"\"; \"\"22. Temporal Lobe Epilepsy Syndromes\"\"; \"\"23. Partial-Onset Seizures and Localization-Related Epilepsy Syndromes\"\""]
[{"$nulls":4},"\"\"24. Generalized Seizures and Generalized Epilepsy Syndromes\"\"\"\"25. Landau-Kleffner Syndrome and Language Dysfunction in Epilepsy\"\"; \"\"26. Rasmussen Encephalitis\"\"; \"\"27. Nonepileptic Paroxysmal Disorders\"\"; \"\"28. Psychogenic Nonepileptic Seizures\"\"; \"\"29. Neurotransmitters and Drug Development in Epilepsy\"\"; \"\"30. "]
[{"$nulls":4},"Antiepileptic Drugs: An Overview\"\"; \"\"31. Principles of Pharmacokinetics and Pharmacogenetics of Anticonvulsants\"\"; \"\"32. Pregnancy, Epilepsy, and Drug Treatment\"\"; \"\"33. Epileptic Drug Treatment in Special Populations\"\""]
[{"$nulls":4},"\"\"34. Systemic Metabolic Consequences of Antiepileptic Medication\"\"\"\"35. Barbiturates\"\"; \"\"36. Benzodiazepines\"\"; \"\"37. Carbamazepine and Oxcarbazepine\"\"; \"\"38. Ethosuximide\"\"; \"\"39. Gabapentin and Pregabalin\"\"; \"\"40. Lamotrigine\"\"; \"\"41. Levetiracetam\"\"; \"\"42. Phenytoin and Fosphenytoin\"\"; \"\"43. Topiramate\"\"; \"\"44. Valproic Acid\"\"; \"\"45. Vigabatrin\"\"; \"\"46. Zonisamide\"\"; \"\"47. Other Antiepileptic Drugs\"\"; \"\"48. Use of Antidepressants in Epilepsy: What All Neurologists Should Know\"\"; \"\"49. Immunotherapy in Epilepsy\"\"; \"\"50. Dietary Therapy for Epilepsy\"\""]
[{"$nulls":4},"\"\"51. Neurostimulation Therapy for Epilepsy\"\"\"\"52. Epilepsy Surgery\"\"; \"\"53. Prognosis and Ongoing Management of Epilepsy\"\"; \"\"54. Neuropsychiatric Comorbidities with Epilepsy in Children and Adolescents\"\"; \"\"55. Epilepsy and Cognition\"\"; \"\"56. Practical Treatment Strategies of Psychiatric Comorbidities in Adults with Epilepsy\"\"; \"\"57. Therapeutic Uses of Seizures in Neuropsychiatry\"\"; \"\"58. Social Challenges Among Children and Adolescents with Intractable Epilepsy\"\"; \"\"59. Monitoring for Adverse Effects of Antiepileptic Drugs\"\"; \"\"Index\"\""]
[null,"2.","Record Nr.",null,"UNISA996199526303316"]
[null,null,"Titolo",null,"Country profile Eritrea, Somalia, Djibouti"]
[null,null,"Pubbl/distr/stampa",null,"London, : Economist Intelligence Unit, c1997-c2003"]
[null,null,"Descrizione fisica",null,"1 online resource"]
[null,null,"Disciplina",null,"330.963/005"]
[null,null,"Soggetti",null,"Economic history"]
[{"$nulls":4},"Politics and government"]
[{"$nulls":4},"Periodicals."]
[{"$nulls":4},"Eritrea Economic conditions Periodicals"]
[{"$nulls":4},"Eritrea Politics and government 1993- Periodicals"]
[{"$nulls":4},"Somalia Economic conditions 1960- Periodicals"]
[{"$nulls":4},"Somalia Politics and government 1991- Periodicals"]
[{"$nulls":4},"Djibouti Economic conditions Periodicals"]
[{"$nulls":4},"Djibouti Politics and government Periodicals"]
[{"$nulls":4},"Djibouti"]
[{"$nulls":4},"Eritrea"]
[{"$nulls":4},"Somalia"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Periodico"]